Article Text

Download PDFPDF

Review of the role of NICE in promoting the adoption of innovative cardiac technologies
  1. Peter H Groves1,
  2. Chris Pomfrett2,
  3. Mirella Marlow3
  1. 1 Chair, Medical Technologies Advisory Committee, National Institute for Health and Care Excellence, Manchester, UK
  2. 2 Medical Technology Evaluation Programme, Centre for Health Technology Evaluation, National Institute for Health and Care Excellence, Manchester, UK
  3. 3 Centre for Health Technology Evaluation, National Institute for Health and Care Excellence, London, UK
  1. Correspondence to Dr Peter H Groves, Chair, Medical Technologies Advisory Committee, National Institute for Health and Care Excellence, Manchester M1 4BT, UK; peter.groves{at}nice.org.uk

Abstract

The National Institute for Health and Care Excellence (NICE) Medical Technologies Evaluation Programme (MTEP) promotes the adoption of innovative diagnostic and therapeutic technologies into National Health Service (NHS) clinical practice through the publication of guidance and briefing documents. Since the inception of the programme in 2009, there have been 7 medical technologiesguidance, 3 diagnostics guidance and 23 medtechinnovation briefing documents published that are relevant to the heart and circulation. Medical technologies guidance is published by NICE for selected single technologies if they offer plausible additional benefits to patients and the healthcare system. Diagnostic guidance is published for diagnostic technologies if they have the potential to improve health outcomes, but if their introduction may be associated with an increase in overall cost to the NHS. Medtechinnovation briefings provide evidence-based advice to those considering the implementation of new medical devices or diagnostic technologies. This review provides reference to all of the guidance and briefing medical technology documents that NICE has published that are relevant to the heart and circulation and reflect on their diverse recommendations. The interaction of MTEP with other NICE programmes is integral to its effectiveness and the means by which consistency is ensured across the different NICE programmes is described. The importance of the input of clinical experts from the cardiovascular professional community and the engagement by NICE with cardiovascular professional societies is highlighted as being fundamental to ensuring the quality of guidance outputs as well as to promoting their implementation and adoption.

  • health care delivery
  • health care economics

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors All authors have made substantial contributions to the conception or design of this paper and have contributed to drafting or revising the paper critically for important intellectual content. Final approval of the version published has been given by all authors. Agreement has been reached by all authors to be accountable for all aspects of the paper to ensure that questions related to accuracy or integrity are appropriately investigated and resolved.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.